Vertex Pharmaceuticals VRTX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.03B+59.6% | $1.19B— | $1.08B+3.6% | $1.03B+129% | $646.3M-41.2% | ||
| $55.9M+15.5% | $55.7M+19.8% | $54M+1.5% | $51.7M-4.3% | $48.4M-9.5% | ||
| $166.4M+0.2% | $157.6M-6.1% | $194.9M+5.6% | $167.3M+8.5% | $166.1M-13.4% | ||
| $1.43B+74.4% | $498M+504% | $1.24B+1,108% | $1.07B+129% | $818.9M-37.3% | ||
| $133.4M+228% | $149.4M+61.3% | $101.8M+50.4% | $145.7M+111% | $40.7M-40.5% | ||
| -$431.9M-674% | -$288.1M+64.9% | -$117M+66.4% | -$484.5M-4.5% | -$55.8M+97.4% | ||
| $336.9M-20.9% | $128.4M-69.3% | $1.07B+248% | $391.8M+22.3% | $426.1M+225% | ||
| -$538.8M+20.8% | -$77.2M+80.3% | -$1.15B-198% | -$349.2M+2.6% | -$680.4M-90.3% | ||
| $417.1M+268% | $140M+121% | $0— | $296.6M+106% | $113.2M+109% | ||
| $1.29B+66.4% | $348.6M+276% | $1.14B+677% | $927.4M+124% | $778.2M-37.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Vertex Pharmaceuticals generate?
- Vertex Pharmaceuticals (VRTX) generated $4.2B in operating cash flow over the trailing twelve months.
- What is Vertex Pharmaceuticals's free cash flow?
- After $530.3M of capital expenditures, Vertex Pharmaceuticals's free cash flow was $3.7B over the trailing twelve months, up 207.9% year over year.
- Where does Vertex Pharmaceuticals's cash flow data come from?
- Every line is extracted from Vertex Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
